HopeStage
Back to all studies
RecruitingNCT05992831

Accelerated TMS dose levels for depression and thinking challenges with mild cognitive impairment

About this titleRead the official source — NCT05992831
Device studyAges 60–85United States
The study in practice

Understand this study

Who could participate?

Listed age limits: 60 years to 85 years.

Listed locations
CharlestonSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: June 18, 2024
Recruitment status
Recruiting
Enrollment listed in the registry
60
Sponsor
Medical University of South Carolina
Sponsor type
University
Study type
Device
Intervention type
Device
Locations
United States
Age range
From 60 Years to 85 Years
Official registry ID
NCT05992831
Official title
Show the full official title

Transcranial Magnetic Stimulation for MCI: A Phase II Dose-Response Study

Recruitment & locations

Currently recruiting

Charleston

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Medical University of South Carolina, a university.

Who can participate?

Listed age limits: 60 years to 85 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies